Delta 9 Cannabis Inc.

DN

CA2477541049

Pharmaceuticals

Delayed Toronto S.E. Other stock markets 20:59:59 15/07/2024 BST			5-day change	1st Jan Change
0.01 ^CAD	0.00%		-33.33%	-60.00%

07-15	FIKA entered into a binding term sheet agreement to acquire Cannabis retail store business and the logistics and distribution business of Delta 9 Cannabis Inc. (TSX:DN).	CI
07-08	SNDL Completes Purchase of Delta 9 Cannabis Debt	MT

FIKA entered into a binding term sheet agreement to acquire Cannabis retail store business and the logistics and distribution business of Delta 9 Cannabis Inc. (TSX:DN).

July 14, 2024

FIKA entered into a binding term sheet agreement to acquire Cannabis retail store business and the logistics and distribution business of Delta 9 Cannabis Inc. (TSX:DN) on July 15, 2024. MLT Aikins LLP acted as legal advisor to Delta 9 Cannabis Inc.

Latest news about Delta 9 Cannabis Inc.

FIKA entered into a binding term sheet agreement to acquire Cannabis retail store business and the logistics and distribution business of Delta 9 Cannabis Inc. (TSX:DN).	07-14	CI
SNDL Completes Purchase of Delta 9 Cannabis Debt	07-08	MT
Transcript : Delta 9 Cannabis Inc., Q1 2024 Earnings Call, May 16, 2024	05-16
Delta 9 Cannabis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-16	CI
Delta 9 Cannabis to Seek Cannabis Stores Acquisition	04-01	CI
Transcript : Delta 9 Cannabis Inc., 2023 Earnings Call, Apr 01, 2024	04-01
Delta 9 Cannabis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
Delta 9 Cannabis Inc. to Supply Bulk Cannabis to Leading Canadian Licensed Producer	01-23	CI
Transcript : Delta 9 Cannabis Inc., Q3 2023 Earnings Call, Nov 15, 2023	11-15
Delta 9 Cannabis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Delta 9 Cannabis Inc. to Supply Cannabis to New Brunswick	30/10/23	CI
Delta 9 Cannabis Inc. announced that it has received $0.05 million in funding from Haywood Securities Inc.	29/08/23	CI
Transcript : Delta 9 Cannabis Inc., Q2 2023 Earnings Call, Aug 15, 2023	15/08/23
Delta 9 Cannabis Reported Financials for Q2 2023	15/08/23	MT
North American Morning Briefing : China Angst -2-	15/08/23	DJ
Delta 9 Cannabis Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Delta 9 Cannabis to Supply Cannabis to Northwest Territories	10/08/23	MT
Delta 9 Cannabis Inc. to Supply Cannabis to Northwest Territories	09/08/23	CI
Delta 9 Cannabis Expanding Distribution Business In Manitoba	03/08/23	MT
Delta 9 Cannabis Provides Revenue Outlook for Q2	27/07/23	MT
Delta 9 Cannabis Secures Grow Pod Contract for Cultivation Facility in British Columbia	14/06/23	MT
Delta 9 Cannabis Inc. Secures A Purchase Order for Grow Pods for Cultivation Facility in British Columbia	13/06/23	CI
Delta 9 Cannabis On Manitoba Government's Bill 10 Amendment to Repeal 6% Social Responsibility Fee	18/05/23	MT
Transcript : Delta 9 Cannabis Inc., Q1 2023 Earnings Call, May 16, 2023	16/05/23
Delta 9 Cannabis' Q1 Loss Narrows, Revenue Rises	16/05/23	MT

Chart Delta 9 Cannabis Inc.

Duration

Period

More charts

Company Profile

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.

Sector

Pharmaceuticals

Calendar

11/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DELTA 9 CANNABIS INC.	-60.00%	2.58M
ELI LILLY AND COMPANY	+62.14%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-3.94%	359B
MERCK & CO., INC.	+15.78%	325B
ABBVIE INC.	+8.93%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+16.10%	177B
PFIZER, INC.	+2.17%	165B